All lobbying filings
Hart Health Strategies
Hart Health Strategies filed a Q3 amendment for Pharmaceutical Research Manufacturers of America on October 26, 2026, reporting no lobbying activity.
Lobbying for Pharmaceutical Research Manufacturers of America
Filing · LD-2 quarterly report
Q3 amendmentNo activity
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 26, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Lobbying activity
0
No itemized activity in this filing.